The CRONIC-PPF Faculty

	Gábor KOVÁCS Ass. Prof. Dr. med. univ., PhD Pulmonary and pulmonary vascular remodeling in patients with end-stage fibrotic interstitial lung disease and different severity of pulmonary vascular disease
Associate Professor, Division of Pulmonology Division of Pulmonology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz Phone: +43-316-385 80748, ✉ e-mail WWW: Forschungsportal Med Uni Graz ORCID: 0000-0003-3709-2183 PubMed: PubMed (nih.gov)
• Profile      • Curriculum vitae     • Publications

Gábor Kovács is a pulmonologist and clinical researcher. He focuses mainly on the early recognition of chronic pulmonary vascular diseases and the development of innovative new diagnostic tools in this field including imaging methods and biomarkers. To his special interests belong the investigation of abnormal pulmonary hemodynamic reactions during exercise which may represent early forms of pulmonary vascular disease.

Project

Research interests

1. We performed extensive research to understand normal and pathologic pulmonary hemodynamics during exercise. We investigated the potential reasons and prognostic relevance of pulmonary exercise hemodynamics. (Kovacs et al., 2009 [↗]; Kovacs et al., 2010 [↗]; Kovacs et al., 2012 [↗]; Kovacs et al., 2012 [↗]; Kovacs et al., 2016 [↗]; Kovacs et al., 2017 [↗]; Zeder et al., 2021 [↗]; Douschan et al., 2022 [↗]; Douschan et al., 2022 [↗]; Sassmann et al., 2022 [↗]; Zeder et al., 2022 [↗]; Gargani et al., 2023 [↗]; Kovacs et al., 2024 [↗])
2. We also performed extensive clinical research on the limits of normal pulmonary hemodynamics and the optimal hemodynamic definition of pulmonary hypertension. (Kovacs et al., 2009 [↗]; Kovacs et al., 2014 [↗]; Douschan et al., 2018 [↗]; Maron et al., 2020 [↗]; Kovacs et al., 2021 [↗]; Kovacs et al., 2022 [↗]; Humbert et al., 2022 [↗]; Douschan et al., 2023 [↗]; Zeder et al., 2024 [↗]; Kovacs et al., 2024 [↗]; Kovacs et al., 2024 [↗])
3. We also investigated the relevance of pulmonary vascular disease in patients with COPD including histopathologic changes and the clinical relevance of hemodynamics. (Kovacs et al., 2018 [↗]; Zeder et al., 2021 [↗]; Kovacs et al., 2021 [↗]; Kovacs et al., 2022 [↗]; Sassmann et al., 2022 [↗]; Zeder et al., 2024 [↗]; Vitulo et al., 2024 [↗]; Tello et al., 2024 [↗])

03.04.2026 CRONIC-PPF · Doctoral Programme “Clinical & Research Oriented Network for Innovative Classification of Progressive Pulmonary Fibrosis”